» Articles » PMID: 28784414

Neutrophilic Inflammation in Asthma and Association with Disease Severity

Overview
Journal Trends Immunol
Date 2017 Aug 9
PMID 28784414
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a chronic inflammatory disorder of the airways. While the local infiltration of eosinophils and mast cells, and their role in the disease have long been recognized, neutrophil infiltration has also been assessed in many clinical studies. In these studies, airway neutrophilia was associated with asthma severity. Importantly, neutrophilia also correlates with asthma that is refractory to corticosteroids, the mainstay of asthma treatment. However, it is now increasingly recognized that neutrophils are a heterogeneous population, and a more precise phenotyping of these cells may help delineate different subtypes of asthma. Here, we review current knowledge of the role of neutrophils in asthma and highlight future avenues of research in this field.

Citing Articles

Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies.

Hussain M, Goyal A, Goyal K, S R, Nellore J, Shahwan M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40047857 DOI: 10.1007/s00210-025-03970-x.


Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell.

Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R Immunol Rev. 2025; 330(1):e70010.

PMID: 40016948 PMC: 11868696. DOI: 10.1111/imr.70010.


Effect of Zataria multiflora supplementation on pro- or anti-inflammatory markers: a systematic review and meta-analysis of randomized placebo-controlled trials.

Moradi A, Aslani F, Boskabady M, Pahlavan Y, Aslani M Inflammopharmacology. 2025; .

PMID: 39992592 DOI: 10.1007/s10787-025-01668-3.


T1-T2 Interplay in the Complex Immune Landscape of Severe Asthma.

Gauthier M, Kale S, Ray A Immunol Rev. 2025; 330(1):e70011.

PMID: 39991821 PMC: 11849004. DOI: 10.1111/imr.70011.


Hyssopus cuspidatus volatile oil: a potential treatment for steroid-resistant asthma via inhibition of neutrophil extracellular traps.

Wang X, Peng H, Zhang M, Li J, Zhao C, Zhang Y Chin Med. 2025; 20(1):17.

PMID: 39901245 PMC: 11792399. DOI: 10.1186/s13020-025-01069-2.


References
1.
Serhan C, Chiang N, Dalli J, Levy B . Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2014; 7(2):a016311. PMC: 4315926. DOI: 10.1101/cshperspect.a016311. View

2.
Ray A, Raundhal M, Oriss T, Ray P, Wenzel S . Current concepts of severe asthma. J Clin Invest. 2016; 126(7):2394-403. PMC: 4922699. DOI: 10.1172/JCI84144. View

3.
Message S, Laza-Stanca V, Mallia P, Parker H, Zhu J, Kebadze T . Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008; 105(36):13562-7. PMC: 2528869. DOI: 10.1073/pnas.0804181105. View

4.
Mautino G, Capony F, Bousquet J, Vignola A . Balance in asthma between matrix metalloproteinases and their inhibitors. J Allergy Clin Immunol. 1999; 104(3 Pt 1):530-3. DOI: 10.1016/s0091-6749(99)70319-2. View

5.
Papp K, Leonardi C, Menter A, Ortonne J, Krueger J, Kricorian G . Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012; 366(13):1181-9. DOI: 10.1056/NEJMoa1109017. View